ArticleClinical and translational science2025

Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas.

Wei-Sheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.